MedPath

Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19)

Phase 1
Recruiting
Conditions
ovel Coronavirus Pneumonia (COVID-19)
Registration Number
ITMCTR2000003078
Lead Sponsor
Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) diagnosed as a mild and common type of the new coronavirus pneumonia, meeting the diagnostic criteria of the new coronavirus pneumonia diagnosis plan (trial version 6), both male and female;
(2) aged 14 to 70 years old;
(3) body temperature > 37.3 degree C;
(4) understand the nature, significance, possible benefits, inconvenience and potential dangers of the test in detail before the test;
(5) understand the study procedure and voluntarily sign the written informed consent (signed by both the patient and the legal guardian for the minor patient).

Exclusion Criteria

(1) patients with severe heart, liver, kidney and other complications or other serious primary disease or mental illness;
(2) patients whose survival time is not expected to exceed 48 hours from screening;
(3) endotracheal intubation and mechanical ventilation had been performed during screening;
(4) any influence on inclusion judged by the researcher.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
self-rating anxiety scale;Self-rating depression scale;Athens Insomnia Scale;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath